AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
AMGN vs REGN Fundamental Comparison
| Metric | AMGN | REGN |
|---|---|---|
| Revenue | $36.8B | $14.3B |
| Net Income | $7.7B | $4.5B |
| Net Margin | 21.0% | 31.4% |
| ROE | 89.1% | 14.4% |
| ROA | 8.5% | 11.1% |
| Current Ratio | 1.14x | 4.13x |
| Debt/Equity | 6.31x | 0.06x |
| EPS | $14.23 | $41.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
AMGN vs REGN: Frequently Asked Questions
Is AMGN or REGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. AMGN is rated BUY (84% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.
How does AMGN compare to REGN fundamentally?
AMGEN INC has ROE of 89.1% vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 21.0% vs 31.4% respectively.
Which stock pays higher dividends, AMGN or REGN?
AMGN has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in AMGN or REGN for long term?
For long-term investing, consider that AMGN has BUY rating with 84% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about AMGN vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For AMGN vs REGN, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.